Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review
Summary Green tea has been associated with positive effects in the treatment of obesity and other associated comorbidities such as type 2 diabetes. These benefits are thought to be related to the anti‐inflammatory and antioxidant effects of green tea and to the reduction in body fat percentage exhib...
Gespeichert in:
| Veröffentlicht in: | Obesity reviews 2016-12, Vol.17 (12), p.1316-1328 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1328 |
|---|---|
| container_issue | 12 |
| container_start_page | 1316 |
| container_title | Obesity reviews |
| container_volume | 17 |
| creator | Ferreira, M.A. Silva, D.M. de Morais Jr, A.C. Mota, J.F. Botelho, P.B. |
| description | Summary
Green tea has been associated with positive effects in the treatment of obesity and other associated comorbidities such as type 2 diabetes. These benefits are thought to be related to the anti‐inflammatory and antioxidant effects of green tea and to the reduction in body fat percentage exhibited by its bioactive compounds. The predominant active compounds in green tea are flavonoid monomers known as catechins, in particular epigallocatechin‐3‐gallate, which is the most abundant and most effective catechin in metabolic care, particularly among obese patients. The objective of this review was to investigate the effects of green tea on body composition, oxidative stress, inflammation and insulin resistance, risk factors for the development of type 2 diabetes in obese individuals and the mechanisms that underlie the modulatory actions of green tea compounds on these risk factors. Although green tea has therapeutic potential in the treatment of obese individuals, the findings of this review demonstrate the need for a greater number of studies to confirm the positive effects of green tea, especially regarding the modulation of obesity. |
| doi_str_mv | 10.1111/obr.12452 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1846419308</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4242651981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4902-78a5a77b6faaedad08c5369711c15ae76895657121219af0b6418555e55b4d5d3</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhi0EoqVw4A8gS1zgkNbfTo6wQEGqKELLx82aJBNwm42D7VD23-Oy7R6QkJg5zBye99WMXkIec3bMS52ENh5zobS4Qw65MraydfP17n6v-QF5kNIFY9w2kt8nB8IqJZWyhwTW3zHCjEv2HZ1Dxil7GGkY6LeIONGMQMNEo0-XdIAuh5joECLN2xmpoL2HFjMm6icaWkxIoV_GnGhFgUb86fHqIbk3wJjw0c08Ip_evF6v3lZn56fvVi_Oqk41TJQzQYO1rRkAsIee1Z2WprGcd1wDWlM32mjLRekGBtYaxWutNWrdql738og82_nOMfxYMGW38anDcYQJw5Icr1WRNJLV_4EKYyU3jSno07_Qi7DEqTxSKGk5E1pcU893VBdDShEHN0e_gbh1nLnriFyJyP2JqLBPbhyXdoP9nrzNpAAnO-DKj7j9t5M7f_nx1rLaKXzK-GuvgHjpyh9Wuy_vT538rNcfhHrlVvI3xkynLw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1837102526</pqid></control><display><type>article</type><title>Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Ferreira, M.A. ; Silva, D.M. ; de Morais Jr, A.C. ; Mota, J.F. ; Botelho, P.B.</creator><creatorcontrib>Ferreira, M.A. ; Silva, D.M. ; de Morais Jr, A.C. ; Mota, J.F. ; Botelho, P.B.</creatorcontrib><description>Summary
Green tea has been associated with positive effects in the treatment of obesity and other associated comorbidities such as type 2 diabetes. These benefits are thought to be related to the anti‐inflammatory and antioxidant effects of green tea and to the reduction in body fat percentage exhibited by its bioactive compounds. The predominant active compounds in green tea are flavonoid monomers known as catechins, in particular epigallocatechin‐3‐gallate, which is the most abundant and most effective catechin in metabolic care, particularly among obese patients. The objective of this review was to investigate the effects of green tea on body composition, oxidative stress, inflammation and insulin resistance, risk factors for the development of type 2 diabetes in obese individuals and the mechanisms that underlie the modulatory actions of green tea compounds on these risk factors. Although green tea has therapeutic potential in the treatment of obese individuals, the findings of this review demonstrate the need for a greater number of studies to confirm the positive effects of green tea, especially regarding the modulation of obesity.</description><identifier>ISSN: 1467-7881</identifier><identifier>EISSN: 1467-789X</identifier><identifier>DOI: 10.1111/obr.12452</identifier><identifier>PMID: 27443447</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Animals ; Antioxidants - pharmacology ; Body Composition ; Camellia sinensis ; Catechin - analogs & derivatives ; Catechin - pharmacology ; diabetes mellitus ; Diabetes Mellitus, Type 2 - drug therapy ; Disease Models, Animal ; Humans ; Inflammation - drug therapy ; Insulin Resistance ; Meta-Analysis as Topic ; obesity ; Obesity - drug therapy ; Oxidative Stress - physiology ; Phytotherapy ; Randomized Controlled Trials as Topic ; Risk Factors ; Tea - chemistry</subject><ispartof>Obesity reviews, 2016-12, Vol.17 (12), p.1316-1328</ispartof><rights>2016 World Obesity Federation</rights><rights>2016 World Obesity Federation.</rights><rights>2016 World Obesity</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4902-78a5a77b6faaedad08c5369711c15ae76895657121219af0b6418555e55b4d5d3</citedby><cites>FETCH-LOGICAL-c4902-78a5a77b6faaedad08c5369711c15ae76895657121219af0b6418555e55b4d5d3</cites><orcidid>0000-0001-8909-3757</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fobr.12452$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fobr.12452$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27443447$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ferreira, M.A.</creatorcontrib><creatorcontrib>Silva, D.M.</creatorcontrib><creatorcontrib>de Morais Jr, A.C.</creatorcontrib><creatorcontrib>Mota, J.F.</creatorcontrib><creatorcontrib>Botelho, P.B.</creatorcontrib><title>Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review</title><title>Obesity reviews</title><addtitle>Obesity Reviews</addtitle><description>Summary
Green tea has been associated with positive effects in the treatment of obesity and other associated comorbidities such as type 2 diabetes. These benefits are thought to be related to the anti‐inflammatory and antioxidant effects of green tea and to the reduction in body fat percentage exhibited by its bioactive compounds. The predominant active compounds in green tea are flavonoid monomers known as catechins, in particular epigallocatechin‐3‐gallate, which is the most abundant and most effective catechin in metabolic care, particularly among obese patients. The objective of this review was to investigate the effects of green tea on body composition, oxidative stress, inflammation and insulin resistance, risk factors for the development of type 2 diabetes in obese individuals and the mechanisms that underlie the modulatory actions of green tea compounds on these risk factors. Although green tea has therapeutic potential in the treatment of obese individuals, the findings of this review demonstrate the need for a greater number of studies to confirm the positive effects of green tea, especially regarding the modulation of obesity.</description><subject>Animals</subject><subject>Antioxidants - pharmacology</subject><subject>Body Composition</subject><subject>Camellia sinensis</subject><subject>Catechin - analogs & derivatives</subject><subject>Catechin - pharmacology</subject><subject>diabetes mellitus</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Disease Models, Animal</subject><subject>Humans</subject><subject>Inflammation - drug therapy</subject><subject>Insulin Resistance</subject><subject>Meta-Analysis as Topic</subject><subject>obesity</subject><subject>Obesity - drug therapy</subject><subject>Oxidative Stress - physiology</subject><subject>Phytotherapy</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Risk Factors</subject><subject>Tea - chemistry</subject><issn>1467-7881</issn><issn>1467-789X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1v1DAQhi0EoqVw4A8gS1zgkNbfTo6wQEGqKELLx82aJBNwm42D7VD23-Oy7R6QkJg5zBye99WMXkIec3bMS52ENh5zobS4Qw65MraydfP17n6v-QF5kNIFY9w2kt8nB8IqJZWyhwTW3zHCjEv2HZ1Dxil7GGkY6LeIONGMQMNEo0-XdIAuh5joECLN2xmpoL2HFjMm6icaWkxIoV_GnGhFgUb86fHqIbk3wJjw0c08Ip_evF6v3lZn56fvVi_Oqk41TJQzQYO1rRkAsIee1Z2WprGcd1wDWlM32mjLRekGBtYaxWutNWrdql738og82_nOMfxYMGW38anDcYQJw5Icr1WRNJLV_4EKYyU3jSno07_Qi7DEqTxSKGk5E1pcU893VBdDShEHN0e_gbh1nLnriFyJyP2JqLBPbhyXdoP9nrzNpAAnO-DKj7j9t5M7f_nx1rLaKXzK-GuvgHjpyh9Wuy_vT538rNcfhHrlVvI3xkynLw</recordid><startdate>201612</startdate><enddate>201612</enddate><creator>Ferreira, M.A.</creator><creator>Silva, D.M.</creator><creator>de Morais Jr, A.C.</creator><creator>Mota, J.F.</creator><creator>Botelho, P.B.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7TS</scope><scope>C1K</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>7U2</scope><orcidid>https://orcid.org/0000-0001-8909-3757</orcidid></search><sort><creationdate>201612</creationdate><title>Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review</title><author>Ferreira, M.A. ; Silva, D.M. ; de Morais Jr, A.C. ; Mota, J.F. ; Botelho, P.B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4902-78a5a77b6faaedad08c5369711c15ae76895657121219af0b6418555e55b4d5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Antioxidants - pharmacology</topic><topic>Body Composition</topic><topic>Camellia sinensis</topic><topic>Catechin - analogs & derivatives</topic><topic>Catechin - pharmacology</topic><topic>diabetes mellitus</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Disease Models, Animal</topic><topic>Humans</topic><topic>Inflammation - drug therapy</topic><topic>Insulin Resistance</topic><topic>Meta-Analysis as Topic</topic><topic>obesity</topic><topic>Obesity - drug therapy</topic><topic>Oxidative Stress - physiology</topic><topic>Phytotherapy</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Risk Factors</topic><topic>Tea - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ferreira, M.A.</creatorcontrib><creatorcontrib>Silva, D.M.</creatorcontrib><creatorcontrib>de Morais Jr, A.C.</creatorcontrib><creatorcontrib>Mota, J.F.</creatorcontrib><creatorcontrib>Botelho, P.B.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Physical Education Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>Safety Science and Risk</collection><jtitle>Obesity reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ferreira, M.A.</au><au>Silva, D.M.</au><au>de Morais Jr, A.C.</au><au>Mota, J.F.</au><au>Botelho, P.B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review</atitle><jtitle>Obesity reviews</jtitle><addtitle>Obesity Reviews</addtitle><date>2016-12</date><risdate>2016</risdate><volume>17</volume><issue>12</issue><spage>1316</spage><epage>1328</epage><pages>1316-1328</pages><issn>1467-7881</issn><eissn>1467-789X</eissn><abstract>Summary
Green tea has been associated with positive effects in the treatment of obesity and other associated comorbidities such as type 2 diabetes. These benefits are thought to be related to the anti‐inflammatory and antioxidant effects of green tea and to the reduction in body fat percentage exhibited by its bioactive compounds. The predominant active compounds in green tea are flavonoid monomers known as catechins, in particular epigallocatechin‐3‐gallate, which is the most abundant and most effective catechin in metabolic care, particularly among obese patients. The objective of this review was to investigate the effects of green tea on body composition, oxidative stress, inflammation and insulin resistance, risk factors for the development of type 2 diabetes in obese individuals and the mechanisms that underlie the modulatory actions of green tea compounds on these risk factors. Although green tea has therapeutic potential in the treatment of obese individuals, the findings of this review demonstrate the need for a greater number of studies to confirm the positive effects of green tea, especially regarding the modulation of obesity.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>27443447</pmid><doi>10.1111/obr.12452</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0001-8909-3757</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1467-7881 |
| ispartof | Obesity reviews, 2016-12, Vol.17 (12), p.1316-1328 |
| issn | 1467-7881 1467-789X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1846419308 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Animals Antioxidants - pharmacology Body Composition Camellia sinensis Catechin - analogs & derivatives Catechin - pharmacology diabetes mellitus Diabetes Mellitus, Type 2 - drug therapy Disease Models, Animal Humans Inflammation - drug therapy Insulin Resistance Meta-Analysis as Topic obesity Obesity - drug therapy Oxidative Stress - physiology Phytotherapy Randomized Controlled Trials as Topic Risk Factors Tea - chemistry |
| title | Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T17%3A37%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20potential%20of%20green%20tea%20on%20risk%20factors%20for%20type%202%20diabetes%20in%20obese%20adults%20-%20a%20review&rft.jtitle=Obesity%20reviews&rft.au=Ferreira,%20M.A.&rft.date=2016-12&rft.volume=17&rft.issue=12&rft.spage=1316&rft.epage=1328&rft.pages=1316-1328&rft.issn=1467-7881&rft.eissn=1467-789X&rft_id=info:doi/10.1111/obr.12452&rft_dat=%3Cproquest_cross%3E4242651981%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1837102526&rft_id=info:pmid/27443447&rfr_iscdi=true |